BRIEF-Richter and Allergan plan to submit new drug application for uterine fibroids in 2017

BUDAPEST May 9 Allergan Plc Richter
Gedeon Nyrt

*Allergan and Richter announce positive phase 3 results for
ulipristal acetate in treatment of uterine fibroids

*New drug application for treatment of uterine fibroids is
planned to be submitted in 2017

Source text: Budapest Stock Exchange website

Further company coverage: AGN.N GDRB.BU


(Reporting by Krisztina Than)

This article is automatically posted by WP-AutoPost Plugin

Source URL:http://www.reuters.com/article/richter-gedeon-allergan-pharmaceuticals-idUSB3N12000T

News

BRIEF-Moody's says Euro Area's economic recovery supports stable 2018 outlook

January 15, 2018 mmayha 0

Jan 15 (Reuters) – Moody‘s: * MOODY‘S SAYS EURO AREA‘S ECONOMIC RECOVERY SUPPORTS STABLE 2018 OUTLOOK, DESPITE PATCHY STRUCTURAL REFORM PROGRESS‍​ * MOODY‘S SAYS FORECASTS THAT EURO AREA GROWTH WILL AVERAGE 2.0 PERCENT IN 2018, […]

News

RPT-Germany to include yuan in FX reserves – c.banker

January 15, 2018 mmayha 0

(Repeats to more subscribers) HONG KONG, Jan 15 (Reuters) – Germany’s central bank has decided to include China’s currency, the yuan, in its foreign exchange reserves, Bundesbank board member Andreas Dombret said in Hong Kong […]

News

Singapore files more charges against Shell oil theft suspects

January 15, 2018 mmayha 0

SINGAPORE (Reuters) – A Singapore court on Monday filed additional charges against nine men accused in a large-scale oil theft at Shell’s biggest refinery, the latest development in an extensive investigation in the city-state. The […]

Be the first to comment

Leave a Reply